Difference between revisions of "Talk:Lung cancer staging"
Jump to navigation
Jump to search
(→Multifocal adenocarcinoma: new section) |
|||
| Line 2: | Line 2: | ||
A separate focus of adenocarcinoma is seen. A synchronous primary cannot be entirely excluded; however, this is presumed to be an intrapulmonary metastasis, as it has a non-lepidic morphology. The case is staged as pT3 on account of the separate focus. | A separate focus of adenocarcinoma is seen. A synchronous primary cannot be entirely excluded; however, this is presumed to be an intrapulmonary metastasis, as it has a non-lepidic morphology. The case is staged as pT3 on account of the separate focus. | ||
<pre> | |||
General Comment - Cancer Staging: | |||
The morphological similarity and immunostaining would be in keeping with a primary tumour and a metastasis; the case was staged under this presumption. | |||
The biomarker findings will provide additional information in the determination: two concurrent primaries VERSUS primary with metastasis. | |||
CLINICAL AND MOLECULAR CORRELATION IS REQUIRED for the staging of this case. | |||
</pre> | |||
Latest revision as of 21:02, 25 August 2023
Multifocal adenocarcinoma
A separate focus of adenocarcinoma is seen. A synchronous primary cannot be entirely excluded; however, this is presumed to be an intrapulmonary metastasis, as it has a non-lepidic morphology. The case is staged as pT3 on account of the separate focus.
General Comment - Cancer Staging: The morphological similarity and immunostaining would be in keeping with a primary tumour and a metastasis; the case was staged under this presumption. The biomarker findings will provide additional information in the determination: two concurrent primaries VERSUS primary with metastasis. CLINICAL AND MOLECULAR CORRELATION IS REQUIRED for the staging of this case.